Medication info
Megateldipin Tablet 40/10 mg

Megateldipin Tablet 40/10 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
A white and light gray, double convex, oval tablet.
Packaging
30 tablets/box [(10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 202000048 · Approved 2020.01.03 · Insurance code 060500180

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, clearance of amlodipine is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used in patients with essential hypertension who have not achieved adequate blood pressure control with monotherapy using telmisartan or amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, clearance of amlodipine is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, and should not be used during pregnancy. It should not be used in individuals with allergies to the active ingredients or similar substances, in pregnant women or those who may become pregnant, in breastfeeding women, in patients with cholestatic disease, in patients with severe liver dysfunction, in patients with left ventricular outflow tract obstruction, in patients with severe hypotension, in patients in a state of shock, in patients with unstable heart failure after acute myocardial infarction, in individuals with issues related to the excipients, and in patients with diabetes or severe renal impairment who are taking specific medications. Careful use is required in patients with primary aldosteronism, certain heart valve diseases, liver disease, gastrointestinal disease, renovascular hypertension, patients on dialysis due to renal failure, elderly patients, and when used in combination with specific antihypertensive agents. Common side effects include dizziness or peripheral edema, and rare side effects may include fainting or severe allergic reactions. During pregnancy, there is an increased risk of fetal renal impairment, cranial formation abnormalities, decreased amniotic fluid, etc., so this medication should be discontinued immediately if pregnancy is confirmed. Since this drug lowers blood pressure, patients with hypotension or dehydration should manage their conditions well prior to taking it. There is a risk of hyperkalemia; potassium levels in the blood should be monitored regularly, and caution is required when taken with potassium supplements or potassium-containing medications. Patients with impaired renal function should take this medication while periodically monitoring renal function and electrolyte levels. Patients with heart disease should be cautious as this medication may increase the risk of angina or myocardial infarction. This medication may cause drowsiness or dizziness; caution is needed when driving or operating hazardous machinery. There may be interactions with other medications, especially when taken with certain heart medications, diuretics, anti-inflammatory drugs, grapefruit juice, etc., so consult with a doctor or pharmacist. Breastfeeding women should avoid taking this medication, and its safety and efficacy have not been established in children, so it is not recommended for them. In the case of overdose, severe hypotension or heart problems may occur, so contact a medical institution immediately and receive necessary treatment. This medication should be kept out of the reach of children and stored in a sealed container to prevent moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
Show 106 more
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormality
  • sensory impairment
  • taste abnormality
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal gas retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver damage
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • voiding disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not let light in. Additionally, it is recommended to store it at room temperature, between 1 to 30 degrees Celsius, for safe storage.

Appearance and packaging

Appearance

A white and light gray, double convex, oval tablet.

Package unit

30 tablets/box [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.